Studies in skeletal tracer kinetics. V: Computer-simulated Tc-99m (Sn)MDP bone-scan changes in some systemic disorders: concise communication.
Using compartmental analysis techniques, we modeled the biodistribution of Tc-99m(Sn)methylene diphosphonate in humans on a computer, and by selectively perturbing appropriate rate constants, we simulated changes in contrast between bone and soft tissue in a number of systemic disorders. The model predicts low contrast in patients with moderate to marked edema, obesity, congestive heart failure or decreased cardiac output states and high contrast with as little as 25% increase in bone avidity for the tracer. In acute renal failure without fluid-volume imbalance, image contrast should be normal. The model predicts greater contrast shortly after injection in patients with increased cardiac output, skeletal blood flow, or bone avidity; images made at these times would be indistinguishable. These simulations are in keeping with reports in the literature of bone images and bone-to-soft tissue ratios in many of these conditions, suggesting that modeling studies could play an important role image interpretation.
D058186:Acute Kidney Injury / Q000000981:diagnostic imaging; D000368:Aged; D001775:Blood Circulation; D001846:Bone Development; D001842:Bone and Bones / Q000098:blood supply / Q000000981:diagnostic imaging*; D002302:Cardiac Output; D003201:Computers; D004164:Diphosphonates; D004487:Edema / Q000000981:diagnostic imaging; D006801:Humans; D007676:Kidney Failure, Chronic / Q000000981:diagnostic imaging; D008875:Middle Aged; D011856:Radiographic Image Enhancement / Q000379:methods; D011877:Radionuclide Imaging; D013667:Technetium; D013669:Technetium Tc 99m Medronate; D013679:Technology, Radiologic
D004164:Diphosphonates; D013667:Technetium; D013669:Technetium Tc 99m Medronate